Uwe Trefzer
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study.
Journal: The British journal of dermatology
Published: September 18, 2019
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients.
Journal: Cancer immunology, immunotherapy : CII
Published: April 18, 2019
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 14, 2017
Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial.
Journal: Oncotarget
Published: March 06, 2017
Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 28, 2015
The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma.
Journal: Journal of the American Academy of Dermatology
Published: August 21, 2015
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial.
Journal: The Lancet. Oncology
Published: May 19, 2015
Actual practice of melanoma follow-up and treatment in Germany: results of a prospective, longitudinal cohort study.
Journal: The British journal of dermatology
Published: December 16, 2014
Remission of an intracardiac melanoma metastasis after tremelimumab therapy.
Journal: Case reports in dermatology
Published: April 08, 2014
Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study.
Journal: Journal for immunotherapy of cancer
Published: March 27, 2014
Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 08, 2014
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 08, 2014
Last Updated: 09/26/2026